Literature DB >> 10398349

Prevalence and correlates of Capgras syndrome in Alzheimer's disease.

D G Harwood1, W W Barker, R L Ownby, R Duara.   

Abstract

OBJECTIVES: This study examined the prevalence and clinical correlates of Capgras syndrome (CS) in Alzheimer's disease.
DESIGN: Cross-sectional study of elderly patients evaluated at an outpatient memory disorders clinic classified according to the presence or absence of CS.
SUBJECTS: One hundred and fifty-one consecutive patients diagnosed with probable (N=110) or possible (N=48) Alzheimer's disease (AD) utilizing NINCDS-ADRDA diagnostic criteria. MATERIALS: The Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), Mini-Mental State Examination (MMSE) and Blessed Dementia Scale (BDS).
RESULTS: CS was observed in 10% of the sample (N=16). Associated factors included other delusions, lower MMSE scores and higher BDS scores. The relation between CS and both cognitive and functional status remained significant after controlling for other delusions.
CONCLUSION: CS was prevalent in approximately 10% of our community-dwelling AD sample. This syndrome was more common at the later stages of the illness and showed relations with increased functional impairment and other psychotic symptomatology. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10398349     DOI: 10.1002/(sici)1099-1166(199906)14:6<415::aid-gps929>3.0.co;2-3

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

1.  Capgras' syndrome in an elderly patient with dementia.

Authors:  Stephanie Sutton; Vedavani Tiruveedhula; Ujjwala Jain; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2014

2.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

3.  Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Martin Steinberg; Kyle Hess; Chris Corcoran; Michelle M Mielke; Maria Norton; John Breitner; Robert Green; Jeannie Leoutsakos; Kathleen Welsh-Bohmer; Constantine Lyketsos; Joann Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2013-05-17       Impact factor: 3.485

4.  Capgras' syndrome in first-episode psychotic disorders.

Authors:  Paola Salvatore; Chaya Bhuvaneswar; Mauricio Tohen; Hari-Mandir K Khalsa; Carlo Maggini; Ross J Baldessarini
Journal:  Psychopathology       Date:  2014-02-07       Impact factor: 1.944

Review 5.  Frontotemporal dementia to Alzheimer's disease.

Authors:  Maria Caterina Silveri
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Uncovering Capgras delusion using a large-scale medical records database.

Authors:  Vaughan Bell; Caryl Marshall; Zara Kanji; Sam Wilkinson; Peter Halligan; Quinton Deeley
Journal:  BJPsych Open       Date:  2017-08-03

7.  Prevalence of Capgras syndrome in Alzheimer's patients: A systematic review and meta-analysis.

Authors:  Gabriela Caparica Muniz Pereira; Gustavo Carvalho de Oliveira
Journal:  Dement Neuropsychol       Date:  2019 Oct-Dec

8.  Cognitive neuroscience of delusions in aging.

Authors:  Anna E M Holt; Martin L Albert
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.